Condition category
Circulatory System
Date applied
23/01/2004
Date assigned
23/01/2004
Last edited
16/06/2014
Prospective/Retrospective
Retrospectively registered
Overall trial status
Completed
Recruitment status
No longer recruiting

Plain English Summary

Not provided at time of registration

Trial website

Contact information

Type

Scientific

Primary contact

Mr P B Wathall

ORCID ID

Contact details

94 Huntington Road
York
YO31 8RP
United Kingdom
+44 (0)1904 640246

Additional identifiers

EudraCT number

ClinicalTrials.gov number

Protocol/serial number

RRCC860F WATHALL

Study information

Scientific title

Acronym

Study hypothesis

Not provided at time of registration

Ethics approval

Not provided at time of registration

Study design

Randomised controlled trial

Primary study design

Interventional

Secondary study design

Randomised controlled trial

Trial setting

Not specified

Trial type

Not Specified

Patient information sheet

Not available in web format, please use the contact details below to request a patient information sheet

Condition

Cardiovascular diseases: Heart disease

Intervention

1. Goal-setting and pacing
2. Standard care
3. Attention control procedure

Intervention type

Other

Phase

Not Applicable

Drug names

Primary outcome measures

The primary outcome will be an increase in fitness measured in (METS) using a standardised exercise test. The patients will also keep an activity diary. Other variables to be measured will include anxiety and depression (Hospital Anxiety and Depression Scale), health beliefs (Illness Perception Questionnaire), this questionnaire has been shown to predict a number of aspects of recovery in post-MI patients, medical co-morbidity, the number of acute events (including hospital admissions), the number of consultations for cardiac reasons, risk factor profile, a cumulative secondary prevention score (using the method of the ASPIRE group), systolic and diastolic blood pressure at rest and following exercise and the EuroQU0L, a measure of health-related quality of life. All of these measures have been validated for use in this patient group and will be piloted during Phase 1 for suitability when other measures may be added.

Secondary outcome measures

Not provided at time of registration

Overall trial start date

08/01/2000

Overall trial end date

03/01/2003

Reason abandoned

Eligibility

Participant inclusion criteria

Coronary care patients

Participant type

Patient

Age group

Not Specified

Gender

Not Specified

Target number of participants

Not provided at time of registration

Participant exclusion criteria

Patients who would normally be offered rehabilitation classes

Recruitment start date

08/01/2000

Recruitment end date

03/01/2003

Locations

Countries of recruitment

United Kingdom

Trial participating centre

94 Huntington Road
York
YO31 8RP
United Kingdom

Sponsor information

Organisation

NHS R&D Regional Programme Register - Department of Health (UK)

Sponsor details

The Department of Health
Richmond House
79 Whitehall
London
SW1A 2NL
United Kingdom
+44 (0)20 7307 2622
dhmail@doh.gsi.org.uk

Sponsor type

Government

Website

http://www.doh.gov.uk

Funders

Funder type

Government

Funder name

NHS Executive Northern and Yorkshire (UK)

Alternative name(s)

Funding Body Type

Funding Body Subtype

Location

Results and Publications

Publication and dissemination plan

Not provided at time of registration

Intention to publish date

Participant level data

Not provided at time of registration

Results - basic reporting

Publication summary

Publication citations

Additional files

Editorial Notes